Gian Carlo Ochoa

ImmuNovus is reimaging drug discovery, development, and health optimization with digital twin technologies. We utilize Quantitative Systems Pharmacology (QSP) computer models coupled with A.I. that characterize biological systems, disease processes, and drug pharmacology. We identify new precise drug targets with high confidence, efficiency, and speed. Using Biological and Biochemical networks, we can characterize treatment effects at the subcellular level.

Güdpod (pronounced ‘good pod’) will transform the $32 billion US nutritional supplement marketplace thru the revolutionary convergence of machine, intelligent software, personalized nutrition delivery and community. At Güdpod we realized that people are more interested than ever in consuming healthy nutrition. But are challenged by the hassle of blenders, shaker cups and multiple pills. So we asked the question, why can’t getting personalized healthy beverages be as easy and convenient to create as brewing a single cup of coffee? Our patented recyclable güpods are single server blenders in a pod and can deliver complex healthy drinks like protein shakes, energy drinks, meal replacements, vitamin beverages, pretty much any beverage that starts out as a powder. The Güdpod machine has no water reservoir, this serves two purposes, eliminates a source of bacteria and allows the consumer to use any liquid of choice (milk, water, Almond/Soy milk, juice, etc.) instead all the blending occurs in the glass which eliminated mess or clean up of the machine. The pod is thrown in the recycling bin and the only thing to clean up is the glass you drank it out of. We recently launched in sports nutrition but believe our platform which is a licensing business model is applicable to any powders beverage. We hope to transform the way consumers get their nutrition one beverage at a time.

Founding board member and Treasurer. As a founding board member, I worked closely alongside the founder and CEO to help set the early vision and strategic direction of the organization's 100% model and various fundraising initiatives. As the organization grew from an idea to a small start-up, I helped serve on various committees including executive, water and finance. Once the organization became more established as a leader in the field, most of my efforts were to help the founder and senior management think about how to scale the business model. During my tenure, I was fortunate to work very closely with this visionary founder and help support him and his incredible team serve 11 million people with clean water.

Hedge Fund

Identified analyzed, and presented equity investment ideas for an event driven long/short value fund. Integrated unique insight, forensic fundamental analysis as well as market sentiment and technical analysis to determine long-term investment strategies as well as short term trading ideas. In 1Q ‘07 this resulted in long ideas that generated a return of 15% and short ideas were down on average (12%). Only one long idea worked against us and underperformed by (3.5%) in this time frame.

business development

Identified, analyzed, and presented equity investment ideas in a wide range of healthcare companies for long/short market neutral portfolio. A fundamental approach to investing with careful consideration to of catalysts. Generated investment ideas that outperformed the overall market and the biotech index with a return on 35%. Investment ideas were 20% of the funds